CVRX / CVRx, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

CVRx, Inc.
US ˙ NasdaqGS ˙ US1266381052

Jumlah Saham Beredar 26,151,724 shares
Saham Orang Dalam11,497,610 shares
Kepemilikan oleh Orang Dalam43.97 %
Orang Dalam Sejati23
Skor Sentimen Orang Dalam

Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.

Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan akumulasi orang dalam tertinggi.

Skor Sentimen Petugas

Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.

Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.

Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan sentimen orang dalam tertinggi.

Metrik Utama Orang Dalam

Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.

Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).

Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)

0 ( )

5246 out of 11323

Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).

Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)

0.000 %( )

5431 out of 11224

Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.

Grafik Perdagangan Orang Dalam

Grafik berikut menunjukkan CVRx, Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.

Daftar Orang Dalam dan Metrik Profitabilitas

Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.

See our leaderboard of most profitable insider traders.

Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan
Adamson Philip B. Chief Medical Officer - [O] 20,000 20,000
John Brintnall CHIEF STRATEGY OFFICER AND SEC - [O] 21,901 21,901
Dean Bruhn-ding VP of Reg. Affairs and QA - [O] 54,648 54,648
Ali Behbahani Director - [D] 316 316
Brent Binkowski CHIEF OPERATING OFFICER - [O] 16,600 16,600
Plc Glaxosmithkline 10% Owner - [10%] 1,007,583 1,007,583
Liz Galle VP OF GLOBAL CLINICAL RESEARCH - [O] 778 778
Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan
Kevin Hykes PRES & CEO, Director - [D] [O] 133,000 133,000
& Johnson Johnson 10% Owner - [10%] 4,103,430 4,103,430
Jain Mudit K. Director - [D] 5,050 5,050
Robert Allen John Chief Revenue Officer - [O] 55,000 55,000
Johnson & Johnson Innovation - JJDC, Inc. 10% Owner - [10%] 3,495,575 4,103,430
Nea Partners 10 L P 10% Owner - [10%] 173,388 173,388
John M Nehra Director - [D] 28,266 28,266
Enterprise Associates 10 L P New 10% Owner - [10%] 2,026,083 2,026,083
Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan
Nielsen Kirk G. Director - [D] 1,910,134 1,910,134
Jared Oasheim CHIEF FINANCIAL OFFICER - [O] 37,447 37,447
Palmer Craig E. SVP, U.S. SALES - [O] 1,229 1,229
Geoffrey B Pardo Director - [D] 1,829,022 1,829,022
Scott D Sandell 10% Owner - [10%] 173,388 173,388
Joseph P Slattery Director - [D] 30,645 30,645
Paul Verrastro CHIEF MKTG & STRAT OFFICER - [O] 16,835 16,835
Nadim Yared CHIEF EXECUTIVE OFFICER, Director - [D] [O] 26,255 26,255

Report errors via our new Insider Auditing Tool

Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di CVRX / CVRx, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2025-05-15 Nielsen Kirk G. 10,966 5.4528 10,966 5.4528 59,795 69 8.6000 34,513 57.72
2025-05-14 Nielsen Kirk G. 61,200 5.2347 61,200 5.2347 320,364
2025-05-13 Nielsen Kirk G. 101,413 5.2884 101,413 5.2884 536,313
2025-05-13 Jain Mudit K. 150 5.2600 150 5.2600 789
2025-05-12 Nielsen Kirk G. 25,200 4.7885 25,200 4.7885 120,670
2025-05-12 Hykes Kevin 5,000 4.8400 5,000 4.8400 24,200
2025-05-12 Jain Mudit K. 1,500 4.6573 1,500 4.6573 6,986
2024-08-15 SLATTERY JOSEPH P 3,000 8.1000 3,000 8.1000 24,300
2024-08-08 SLATTERY JOSEPH P 3,000 8.2386 3,000 8.2386 24,716

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

CVRX / CVRx, Inc. Insider Trades
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek

Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di CVRX / CVRx, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2024-11-19 VERRASTRO PAUL 1,430 13.5781 1,430 13.5781 19,417 174 4.7500 -12,624 -65.02
2024-02-20 VERRASTRO PAUL 2,545 21.9050 2,545 21.9050 55,748
2024-02-16 JOHNSON & JOHNSON 3,725 25.8100 3,725 25.8100 96,142
2023-08-03 VERRASTRO PAUL 628 18.5549 628 18.5549 11,652
2023-07-31 VERRASTRO PAUL 1,122 17.4948 1,122 17.4948 19,629
2022-11-28 VERRASTRO PAUL 600 12.5217 600 12.5217 7,513
2022-11-28 VERRASTRO PAUL 4,000 11.8545 4,000 11.8545 47,418

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

CVRX / CVRx, Inc. Insider Trades
Riwayat Transaksi

Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.

Berkas
Tanggal
Perdagangan
Tanggal
Formulir Orang Dalam Ticker Judul Keamanan Kode 10b5-1 Langsung Latihan
Harga
Satuan
Harga
Unit
Diubah
Nilai
Diubah (1 ribu)
Sisa
Pilihan
Sisa
Saham
2025-08-13 2025-08-11 4 Binkowski Brent CVRX Common Stock A - Award D 16,600 16,600
2025-05-19 2025-05-15 4 Nielsen Kirk G. CVRX Common Stock P - Purchase I 5.4528 10,966 60 1,910,134
2025-05-14 2025-05-14 4 Nielsen Kirk G. CVRX Common Stock P - Purchase I 5.2347 61,200 320 1,899,168
2025-05-14 2025-05-13 4 Nielsen Kirk G. CVRX Common Stock P - Purchase I 5.2884 101,413 536 1,837,968
2025-05-14 2025-05-12 4 Nielsen Kirk G. CVRX Common Stock P - Purchase I 4.7885 25,200 121 1,736,555
2025-05-13 2025-05-13 4 Jain Mudit K. CVRX Common Stock P - Purchase D 5.2600 150 1 5,050
2025-05-13 2025-05-12 4 Jain Mudit K. CVRX Common Stock P - Purchase D 4.6573 1,500 7 4,900
2025-05-12 2025-05-12 4 Hykes Kevin CVRX Common Stock P - Purchase D 4.8400 5,000 24 133,000
2025-03-04 2025-02-28 4 Hykes Kevin CVRX Common Stock A - Award D 98,000 128,000
2025-03-04 2025-02-28 4 John Robert Allen CVRX Common Stock A - Award D 55,000 55,000
2025-03-04 2025-02-28 4 Adamson Philip B. CVRX Common Stock A - Award D 20,000 20,000
2025-03-04 2025-02-28 4 OASHEIM JARED CVRX Common Stock A - Award D 22,000 37,447
2025-03-04 2025-02-28 4 VERRASTRO PAUL CVRX Common Stock A - Award D 16,000 16,835
2024-11-21 2024-11-21 4 VERRASTRO PAUL CVRX Common Stock G - Gift D -1,040 835
2024-11-21 2024-11-19 4 VERRASTRO PAUL CVRX Common Stock S - Sale D 13.5781 -1,430 -19 1,875
2024-11-21 2024-11-19 4 VERRASTRO PAUL CVRX Common Stock M - Exercise D 5.1410 2,500 13 3,305
2024-08-15 2024-08-15 4 SLATTERY JOSEPH P CVRX Common Stock P - Purchase D 8.1000 3,000 24 30,645
2024-08-08 2024-08-08 4 SLATTERY JOSEPH P CVRX Common Stock P - Purchase D 8.2386 3,000 25 27,645
2024-08-06 2024-08-06 4 SLATTERY JOSEPH P CVRX Common Stock P - Purchase D 9.0900 2,500 23 24,645
2024-08-05 2024-08-05 4 Hykes Kevin CVRX Common Stock P - Purchase D 8.3589 30,000 251 30,000
2024-03-27 2024-03-25 4 Palmer Craig E. CVRX Common Stock M - Exercise D 0.2370 151 0 1,229
2024-03-27 2024-03-25 4 Palmer Craig E. CVRX Common Stock M - Exercise D 0.2370 404 0 1,078
2024-03-27 2024-03-25 4 Palmer Craig E. CVRX Common Stock M - Exercise D 0.2370 379 0 674
2024-03-06 2024-02-29 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Common Stock M - Exercise I 5.1410 79 0 4,103,430
2024-03-06 2024-02-29 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Common Stock M - Exercise I 3.9550 252 1 4,103,351
2024-03-06 2024-02-29 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Common Stock M - Exercise I 1.1860 142 0 4,103,099
2024-03-06 2024-02-29 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Common Stock M - Exercise I 1.1860 442 1 4,102,957
2024-03-06 2024-02-29 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Common Stock M - Exercise I 0.2370 300 0 4,102,515
2024-03-06 2024-02-29 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Common Stock M - Exercise I 0.2370 584 0 4,102,215
2024-03-06 2024-02-29 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Common Stock M - Exercise I 0.2370 489 0 4,101,631
2024-03-06 2024-02-29 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Common Stock M - Exercise I 0.2370 758 0 4,101,142
2024-03-06 2024-02-29 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Common Stock M - Exercise I 0.2370 85 0 4,100,384
2024-03-06 2024-02-29 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Common Stock M - Exercise I 0.2370 23 0 4,100,299
2024-03-06 2024-02-29 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Common Stock M - Exercise I 0.2370 71 0 4,100,276
2024-03-06 2024-02-29 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Common Stock M - Exercise I 0.2370 118 0 4,100,205
2024-03-06 2024-02-29 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Common Stock M - Exercise I 0.2370 165 0 4,100,087
2024-03-06 2024-02-29 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Common Stock M - Exercise I 0.2370 189 0 4,099,922
2024-03-06 2024-02-29 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Common Stock M - Exercise I 0.2370 158 0 4,099,733
2024-03-06 2024-02-16 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Common Stock S - Sale I 25.8100 -3,725 -96 4,099,575
2024-03-06 2024-02-16 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Common Stock X - Other I 0.1580 607,725 96 4,103,300
2024-02-27 2024-02-23 4 VERRASTRO PAUL CVRX Common Stock G - Gift D -1,650 805
2024-02-22 2024-02-20 4 VERRASTRO PAUL CVRX Common Stock S - Sale D 21.9050 -2,545 -56 2,455
2024-02-22 2024-02-20 4 VERRASTRO PAUL CVRX Common Stock M - Exercise D 5.1410 5,000 26 5,000
2024-01-31 2024-01-29 4 Yared Nadim CVRX Common Stock M - Exercise D 0.2370 1,945 0 26,255
2024-01-31 2024-01-29 4 Yared Nadim CVRX Common Stock M - Exercise D 0.2370 4,055 1 24,310
2024-01-02 2023-12-28 4 SLATTERY JOSEPH P CVRX Common Stock M - Exercise D 3.9550 96 0 22,145
2024-01-02 2023-12-28 4 SLATTERY JOSEPH P CVRX Common Stock M - Exercise D 1.1860 174 0 22,049
2024-01-02 2023-12-28 4 SLATTERY JOSEPH P CVRX Common Stock M - Exercise D 0.2370 1,456 0 21,875
2024-01-02 2023-12-28 4 SLATTERY JOSEPH P CVRX Common Stock M - Exercise D 0.2370 224 0 20,419
2023-12-18 2023-12-14 4 Behbahani Ali CVRX Common Stock M - Exercise D 0.2370 316 0 316
2023-10-18 2023-10-16 4 Galle Liz CVRX Common Stock M - Exercise D 0.2370 778 0 778
2023-09-20 2023-09-18 4 OASHEIM JARED CVRX Common Stock M - Exercise D 3.9550 5,335 21 15,447
2023-09-20 2023-09-18 4 OASHEIM JARED CVRX Common Stock M - Exercise D 0.2370 527 0 10,112
2023-09-18 3 Johnson & Johnson Innovation - JJDC, Inc. CVRX Common Stock D 3,495,575
2023-09-18 2023-09-15 4 Johnson & Johnson Innovation - JJDC, Inc. CVRX Common Stock J - Other D -3,495,575 0
2023-08-07 2023-08-03 4 VERRASTRO PAUL CVRX Common Stock S - Sale D 18.5549 -628 -12 0
2023-08-02 2023-08-02 4 VERRASTRO PAUL CVRX Common Stock G - Gift D -2,000 628
2023-08-02 2023-07-31 4 VERRASTRO PAUL CVRX Common Stock S - Sale D 17.4948 -1,122 -20 2,628
2023-08-02 2023-07-31 4 VERRASTRO PAUL CVRX Common Stock M - Exercise D 5.1410 3,750 19 3,750
2023-05-18 2023-05-16 4 Palmer Craig E. CVRX Common Stock M - Exercise D 0.2370 295 0 295
2023-01-13 2023-01-11 4 Yared Nadim CVRX Common Stock G - Gift D -7,080 20,255
2022-11-30 2022-11-30 4 VERRASTRO PAUL CVRX Common Stock G - Gift D -4,400 0
2022-11-30 2022-11-28 4 VERRASTRO PAUL CVRX Common Stock S - Sale D 12.5217 -600 -8 4,400
2022-11-30 2022-11-28 4 VERRASTRO PAUL CVRX Common Stock S - Sale D 11.8545 -4,000 -47 5,000
2022-11-30 2022-11-28 4 VERRASTRO PAUL CVRX Common Stock M - Exercise D 5.1410 9,000 46 9,000
2022-06-06 2022-06-02 4 OASHEIM JARED CVRX Common Stock M - Exercise D 0.2370 2,633 1 9,585
2022-06-06 2022-06-02 4 OASHEIM JARED CVRX Common Stock M - Exercise D 0.2370 3,160 1 6,952
2022-06-06 2022-06-02 4 OASHEIM JARED CVRX Common Stock M - Exercise D 0.2370 2,528 1 3,792
2022-06-06 2022-06-02 4 OASHEIM JARED CVRX Common Stock M - Exercise D 0.2370 1,264 0 1,264
2022-05-26 2022-05-24 4 Nielsen Kirk G. CVRX Common Stock P - Purchase I 5.0498 8,070 41 1,711,355
2022-05-23 2022-05-23 4 Nielsen Kirk G. CVRX Common Stock P - Purchase I 5.0396 4,432 22 1,703,285
2022-05-23 2022-05-20 4 Nielsen Kirk G. CVRX Common Stock P - Purchase I 5.0354 13,387 67 1,698,853
2022-05-23 2022-05-19 4 Nielsen Kirk G. CVRX Common Stock P - Purchase I 5.0380 10,976 55 1,685,466
2022-05-02 2022-05-02 4 Nielsen Kirk G. CVRX Common Stock P - Purchase I 5.9701 41,988 251 1,612,186
2022-05-02 2022-04-28 4 Nielsen Kirk G. CVRX Common Stock P - Purchase I 5.9700 100 1 1,570,198
2022-04-27 2022-04-25 4 Yared Nadim CVRX Stock Option (right to buy) M - Exercise D 0.24 -6,059 4,055
2022-04-27 2022-04-25 4 Yared Nadim CVRX Common Stock M - Exercise D 0.2370 6,059 1 27,335
2022-04-26 2022-04-22 4 BRINTNALL JOHN CVRX Stock Option (right to buy) M - Exercise D 0.24 -1,264 0
2022-04-26 2022-04-22 4 BRINTNALL JOHN CVRX Stock Option (right to buy) M - Exercise D 0.24 -3,792 0
2022-04-26 2022-04-22 4 BRINTNALL JOHN CVRX Stock Option (right to buy) M - Exercise D 0.24 -2,221 0
2022-04-26 2022-04-22 4 BRINTNALL JOHN CVRX Stock Option (right to buy) M - Exercise D 0.24 -2,584 702
2022-04-26 2022-04-22 4 BRINTNALL JOHN CVRX Stock Option (right to buy) M - Exercise D 0.24 -1,590 685
2022-04-26 2022-04-22 4 BRINTNALL JOHN CVRX Common Stock M - Exercise D 0.2370 1,264 0 21,901
2022-04-26 2022-04-22 4 BRINTNALL JOHN CVRX Common Stock M - Exercise D 0.2370 3,792 1 20,637
2022-04-26 2022-04-22 4 BRINTNALL JOHN CVRX Common Stock M - Exercise D 0.2370 2,221 1 16,845
2022-04-26 2022-04-22 4 BRINTNALL JOHN CVRX Common Stock M - Exercise D 0.2370 2,584 1 14,624
2022-04-26 2022-04-22 4 BRINTNALL JOHN CVRX Common Stock M - Exercise D 0.2370 1,590 0 12,040
2022-03-02 2022-02-28 4 Jain Mudit K. CVRX Common Stock P - Purchase D 9.0327 600 5 3,400
2022-02-28 2022-02-24 4 Nielsen Kirk G. CVRX Common Stock P - Purchase I 8.2381 3,400 28 1,570,098
2022-02-23 2022-02-23 4 Nielsen Kirk G. CVRX Common Stock P - Purchase I 8.0404 38,200 307 1,566,698
2022-02-23 2022-02-22 4 Nielsen Kirk G. CVRX Common Stock P - Purchase I 7.9399 40,008 318 1,528,498
2022-02-23 2022-02-18 4 Nielsen Kirk G. CVRX Common Stock P - Purchase I 7.9233 26,659 211 1,488,490
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Stock Option (right to buy) M - Exercise D 0.24 -5,158 2,048
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Stock Option (right to buy) M - Exercise D 0.24 -2,275 0
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Stock Option (right to buy) M - Exercise D 0.24 -2,528 0
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Stock Option (right to buy) M - Exercise D 0.24 -2,528 0
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Stock Option (right to buy) M - Exercise D 0.24 -1,590 0
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Stock Option (right to buy) M - Exercise D 0.24 -378 0
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Stock Option (right to buy) M - Exercise D 0.24 -821 0
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Stock Option (right to buy) M - Exercise D 0.24 -1,169 0
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Stock Option (right to buy) M - Exercise D 0.24 -1,264 0
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Stock Option (right to buy) M - Exercise D 0.24 -1,264 0
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Stock Option (right to buy) M - Exercise D 0.24 -2,862 0
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Stock Option (right to buy) M - Exercise D 0.24 -12,383 4,128
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Stock Option (right to buy) M - Exercise D 0.24 -780 315
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Common Stock M - Exercise D 0.2370 5,158 1 54,648
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Common Stock M - Exercise D 0.2370 2,275 1 49,490
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Common Stock M - Exercise D 0.2370 2,528 1 47,215
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Common Stock M - Exercise D 0.2370 2,528 1 47,215
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Common Stock M - Exercise D 0.2370 1,590 0 44,687
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Common Stock M - Exercise D 0.2370 378 0 43,097
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Common Stock M - Exercise D 0.2370 821 0 42,719
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Common Stock M - Exercise D 0.2370 1,169 0 41,898
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Common Stock M - Exercise D 0.2370 1,264 0 38,201
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Common Stock M - Exercise D 0.2370 1,264 0 38,201
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Common Stock M - Exercise D 0.2370 2,862 1 35,673
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Common Stock M - Exercise D 0.2370 12,383 3 32,811
2022-02-10 2022-02-08 4 BRUHN-DING DEAN CVRX Common Stock M - Exercise D 0.2370 780 0 20,428
2022-02-07 2022-02-03 4 Yared Nadim CVRX Common Stock M - Exercise D 0.24 -1,266 11,375
2022-02-07 2022-02-03 4 Yared Nadim CVRX Stock Option (right to buy) M - Exercise D 0.24 -5,916 0
2022-02-07 2022-02-03 4 Yared Nadim CVRX Stock Option (right to buy) M - Exercise D 0.24 -3,792 0
2022-02-07 2022-02-03 4 Yared Nadim CVRX Stock Option (right to buy) M - Exercise D 0.24 -5,057 0
2022-02-07 2022-02-03 4 Yared Nadim CVRX Stock Option (right to buy) M - Exercise D 0.24 -2,659 0
2022-02-07 2022-02-03 4 Yared Nadim CVRX Common Stock M - Exercise D 0.2370 1,266 0 21,276
2022-02-07 2022-02-03 4 Yared Nadim CVRX Common Stock M - Exercise D 0.2370 5,916 1 20,010
2022-02-07 2022-02-03 4 Yared Nadim CVRX Common Stock M - Exercise D 0.2370 3,792 1 14,094
2022-02-07 2022-02-03 4 Yared Nadim CVRX Common Stock M - Exercise D 0.2370 5,057 1 10,302
2022-02-07 2022-02-03 4 Yared Nadim CVRX Common Stock M - Exercise D 0.2370 2,659 1 5,245
2022-01-20 2022-01-19 4 Yared Nadim CVRX Common Stock G - Gift D -10,500 2,586
2022-01-20 2022-01-18 4 Yared Nadim CVRX Stock Option (right to buy) A - Award D 9.08 186,400 186,400
2022-01-20 2022-01-18 4 Galle Liz CVRX Stock Option (right to buy) A - Award D 9.08 25,900 25,900
2022-01-20 2022-01-18 4 BRUHN-DING DEAN CVRX Stock Option (right to buy) A - Award D 9.08 23,600 23,600
2022-01-20 2022-01-18 4 OASHEIM JARED CVRX Stock Option (right to buy) A - Award D 9.08 56,200 56,200
2022-01-20 2022-01-18 4 VERRASTRO PAUL CVRX Stock Option (right to buy) A - Award D 9.08 41,200 41,200
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Stock Option (right to buy) M - Exercise D 1.19 -584 174
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Stock Option (right to buy) M - Exercise D 0.24 -758 0
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Stock Option (right to buy) M - Exercise D 0.24 -316 0
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Stock Option (right to buy) M - Exercise D 0.24 -316 0
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Stock Option (right to buy) M - Exercise D 0.24 -189 0
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Stock Option (right to buy) M - Exercise D 0.24 -189 0
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Stock Option (right to buy) M - Exercise D 0.24 -189 0
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Stock Option (right to buy) M - Exercise D 0.24 -189 0
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Stock Option (right to buy) M - Exercise D 0.24 -2,528 0
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Stock Option (right to buy) M - Exercise D 0.24 -316 0
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Stock Option (right to buy) M - Exercise D 0.24 -3,917 1,456
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Stock Option (right to buy) M - Exercise D 0.24 -2,149 224
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Common Stock M - Exercise D 1.1860 584 1 20,195
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Common Stock M - Exercise D 0.2370 758 0 19,611
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Common Stock M - Exercise D 0.2370 316 0 18,853
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Common Stock M - Exercise D 0.2370 316 0 18,853
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Common Stock M - Exercise D 0.2370 189 0 18,537
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Common Stock M - Exercise D 0.2370 189 0 18,537
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Common Stock M - Exercise D 0.2370 189 0 18,348
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Common Stock M - Exercise D 0.2370 189 0 18,159
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Common Stock M - Exercise D 0.2370 2,528 1 17,781
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Common Stock M - Exercise D 0.2370 316 0 15,253
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Common Stock M - Exercise D 0.2370 3,917 1 14,621
2022-01-18 2022-01-13 4 SLATTERY JOSEPH P CVRX Common Stock M - Exercise D 0.2370 2,149 1 10,704
2022-01-03 2021-12-30 4 BRINTNALL JOHN CVRX Stock Option (right to buy) M - Exercise D 0.24 -2,550 2,221
2022-01-03 2021-12-30 4 BRINTNALL JOHN CVRX Common Stock M - Exercise D 0.2370 2,550 1 10,450
2021-12-30 2021-12-28 4 Yared Nadim CVRX Stock Option (right to buy) M - Exercise D 0.24 -2,080 2,659
2021-12-30 2021-12-28 4 Yared Nadim CVRX Common Stock M - Exercise D 0.2370 2,080 0 13,086
2021-12-02 2021-11-30 4 SLATTERY JOSEPH P CVRX Stock Option (right to buy) M - Exercise D 0.24 -3,000 2,373
2021-12-02 2021-11-30 4 SLATTERY JOSEPH P CVRX Common Stock M - Exercise D 0.2400 3,000 1 8,555
2021-11-29 2021-11-24 4 BRUHN-DING DEAN CVRX Stock Option (right to buy) M - Exercise D 0.24 -14,000 1,095
2021-11-29 2021-11-24 4 BRUHN-DING DEAN CVRX Common Stock M - Exercise D 0.2400 14,000 3 19,648
2021-11-24 2021-11-22 4 Yared Nadim CVRX Stock Option (right to buy) M - Exercise D 0.24 -11,006 4,739
2021-11-24 2021-11-22 4 Yared Nadim CVRX Common Stock M - Exercise D 0.2400 11,006 3 11,006
2021-11-19 2021-11-19 4 Jain Mudit K. CVRX Common Stock P - Purchase D 13.6875 300 4 2,800
2021-11-19 2021-11-18 4 Jain Mudit K. CVRX Common Stock P - Purchase D 14.6327 875 13 2,500
2021-08-16 2021-08-12 4 Jain Mudit K. CVRX Common Stock P - Purchase D 19.7248 625 12 1,625
2021-07-14 2021-07-12 4 SHADAN MARTHA CVRX Stock Option (right to buy) A - Award D 20.10 24,885 24,885
2021-07-14 2021-07-12 4 SHADAN MARTHA CVRX Stock Option (right to buy) A - Award D 20.10 9,988 9,988
2021-07-07 2021-07-02 4 NEW ENTERPRISE ASSOCIATES 10 L P CVRX Series G Preferred Stock C - Conversion D -18,934,168 0
2021-07-07 2021-07-02 4 NEW ENTERPRISE ASSOCIATES 10 L P CVRX Series F-2 Preferred Stock C - Conversion D -10,029,566 0
2021-07-07 2021-07-02 4 NEW ENTERPRISE ASSOCIATES 10 L P CVRX Series E-2 Preferred Stock C - Conversion D -3,298,154 0
2021-07-07 2021-07-02 4 NEW ENTERPRISE ASSOCIATES 10 L P CVRX Series D-2 Preferred Stock C - Conversion D -3,170,896 0
2021-07-07 2021-07-02 4 NEW ENTERPRISE ASSOCIATES 10 L P CVRX Series C-2 Preferred Stock C - Conversion D -2,810,950 0
2021-07-07 2021-07-02 4 NEW ENTERPRISE ASSOCIATES 10 L P CVRX Series B-2 Preferred Stock C - Conversion D -2,263,778 0
2021-07-07 2021-07-02 4 NEW ENTERPRISE ASSOCIATES 10 L P CVRX Series A-2 Preferred Stock C - Conversion D -2,300,708 0
2021-07-07 2021-07-02 4 NEW ENTERPRISE ASSOCIATES 10 L P CVRX Common Stock P - Purchase D 18.0000 225,500 4,059 2,026,083
2021-07-07 2021-07-02 4 NEW ENTERPRISE ASSOCIATES 10 L P CVRX Common Stock C - Conversion D 1,196,911 1,800,583
2021-07-07 2021-07-02 4 NEW ENTERPRISE ASSOCIATES 10 L P CVRX Common Stock C - Conversion D 253,605 603,672
2021-07-07 2021-07-02 4 NEW ENTERPRISE ASSOCIATES 10 L P CVRX Common Stock C - Conversion D 83,396 350,067
2021-07-07 2021-07-02 4 NEW ENTERPRISE ASSOCIATES 10 L P CVRX Common Stock C - Conversion D 80,178 266,671
2021-07-07 2021-07-02 4 NEW ENTERPRISE ASSOCIATES 10 L P CVRX Common Stock C - Conversion D 71,077 186,493
2021-07-07 2021-07-02 4 NEW ENTERPRISE ASSOCIATES 10 L P CVRX Common Stock C - Conversion D 57,241 115,416
2021-07-07 2021-07-02 4 NEW ENTERPRISE ASSOCIATES 10 L P CVRX Common Stock C - Conversion D 58,175 58,175
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 4 CVRX Series G Preferred Stock C - Conversion I -1,470,416 0
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 4 CVRX Series F-2 Preferred Stock C - Conversion I -777,752 0
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 4 CVRX Series D-2 Preferred Stock C - Conversion I -410,162 0
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 4 CVRX Series C-2 Preferred Stock C - Conversion I -369,115 0
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 4 CVRX Series B-2 Preferred Stock C - Conversion I -590,551 0
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 2 CVRX Series G Preferred Stock C - Conversion I -18,934,168 0
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 2 CVRX Series F-2 Preferred Stock C - Conversion I -10,029,566 0
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 2 CVRX Series E-2 Preferred Stock C - Conversion I -3,298,154 0
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 2 CVRX Series D-2 Preferred Stock C - Conversion I -3,170,896 0
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 2 CVRX Series C-2 Preferred Stock C - Conversion I -2,810,950 0
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 2 CVRX Series B-2 Preferred Stock C - Conversion I -2,263,778 0
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 2 CVRX Series A-2 Preferred Stock C - Conversion I -2,300,708 0
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 4 CVRX Common Stock P - Purchase I 18.0000 24,750 446 173,388
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 4 CVRX Common Stock C - Conversion I 92,951 148,638
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 4 CVRX Common Stock C - Conversion I 19,666 55,687
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 4 CVRX Common Stock C - Conversion I 10,371 36,021
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 4 CVRX Common Stock C - Conversion I 9,333 25,650
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 4 CVRX Common Stock C - Conversion I 14,933 16,317
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 2 CVRX Common Stock P - Purchase I 18.0000 225,500 4,059 2,026,083
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 2 CVRX Common Stock C - Conversion I 1,196,911 1,800,583
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 2 CVRX Common Stock C - Conversion I 253,605 603,672
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 2 CVRX Common Stock C - Conversion I 83,396 350,067
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 2 CVRX Common Stock C - Conversion I 80,178 266,671
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 2 CVRX Common Stock C - Conversion I 71,077 186,493
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 2 CVRX Common Stock C - Conversion I 57,241 115,416
2021-07-07 2021-07-02 4 NEA PARTNERS 10 L P See Note 2 CVRX Common Stock C - Conversion I 58,175 58,175
2021-07-06 2021-07-02 4 GLAXOSMITHKLINE PLC CVRX Series G Preferred Stock C - Conversion I -10,055,408 0
2021-07-06 2021-07-02 4 GLAXOSMITHKLINE PLC CVRX Series F-2 Preferred Stock C - Conversion I -1,081,434 0
2021-07-06 2021-07-02 4 GLAXOSMITHKLINE PLC CVRX Series E-2 Preferred Stock C - Conversion I -331,399 0
2021-07-06 2021-07-02 4 GLAXOSMITHKLINE PLC CVRX Series D-2 Preferred Stock C - Conversion I -589,939 0
2021-07-06 2021-07-02 4 GLAXOSMITHKLINE PLC CVRX Series C-2 Preferred Stock C - Conversion I -513,312 0
2021-07-06 2021-07-02 4 GLAXOSMITHKLINE PLC CVRX Series B-2 Preferred Stock C - Conversion I -59,527 0
2021-07-06 2021-07-02 4 GLAXOSMITHKLINE PLC CVRX Common Stock P - Purchase I 18.0000 275,000 4,950 1,007,583
2021-07-06 2021-07-02 4 GLAXOSMITHKLINE PLC CVRX Common Stock C - Conversion I 635,646 732,583
2021-07-06 2021-07-02 4 GLAXOSMITHKLINE PLC CVRX Common Stock C - Conversion I 27,345 96,937
2021-07-06 2021-07-02 4 GLAXOSMITHKLINE PLC CVRX Common Stock C - Conversion I 8,380 69,592
2021-07-06 2021-07-02 4 GLAXOSMITHKLINE PLC CVRX Common Stock C - Conversion I 14,917 61,212
2021-07-06 2021-07-02 4 GLAXOSMITHKLINE PLC CVRX Common Stock C - Conversion I 12,979 46,295
2021-07-06 2021-07-02 4 GLAXOSMITHKLINE PLC CVRX Common Stock C - Conversion I 1,505 33,316
2021-07-02 2021-07-02 4 NEHRA JOHN M CVRX Common Stock P - Purchase D 18.0000 27,777 500 28,266
2021-07-02 2021-07-01 4 NEHRA JOHN M As custodian for UTMA account for grandson CVRX Common Stock P - Purchase I 25.8000 50 1 100
2021-07-02 2021-06-30 4 NEHRA JOHN M As custodian for UTMA account for grandson CVRX Common Stock P - Purchase I 27.4257 50 1 50
2021-07-02 2021-07-02 4 SLATTERY JOSEPH P CVRX Common Stock A - Award D 18.0000 5,555 100 5,555
2021-07-02 2021-07-02 4 Nielsen Kirk G. CVRX Series G Preferred Stock C - Conversion I -23,125,000 0
2021-07-02 2021-07-02 4 Nielsen Kirk G. CVRX Common Stock C - Conversion I 1,461,831 1,461,831
2021-07-02 2021-07-02 4 Jain Mudit K. CVRX Series G Preferred Stock C - Conversion I -11,250,000 0
2021-07-02 2021-07-02 4 Jain Mudit K. CVRX Common Stock P - Purchase I 18.0000 222,222 4,000 933,383
2021-07-02 2021-07-02 4 Jain Mudit K. CVRX Common Stock C - Conversion I 711,161 711,161
2021-07-02 2021-07-01 4 Jain Mudit K. CVRX Common Stock P - Purchase D 25.1000 1,000 25 1,000
2021-07-02 2021-07-02 4 Pardo Geoffrey B CVRX Series G Preferred Stock C - Conversion I -24,583,397 0
2021-07-02 2021-07-02 4 Pardo Geoffrey B CVRX Common Stock P - Purchase I 18.0000 275,000 4,950 1,829,022
2021-07-02 2021-07-02 4 Pardo Geoffrey B CVRX Common Stock C - Conversion I 1,554,022 1,554,022
2021-07-02 2021-07-02 4 BRINTNALL JOHN CVRX Series G-2 Preferred Stock C - Conversion D -89,518 0
2021-07-02 2021-07-02 4 BRINTNALL JOHN CVRX Series F-2 Preferred Stock C - Conversion D -88,653 0
2021-07-02 2021-07-02 4 BRINTNALL JOHN CVRX Common Stock C - Conversion D 5,658 7,900
2021-07-02 2021-07-02 4 BRINTNALL JOHN CVRX Common Stock C - Conversion D 2,242 2,242
2021-07-02 2021-07-02 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Series G Preferred Stock C - Conversion I -48,068,690 0
2021-07-02 2021-07-02 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Series F-2 Preferred Stock C - Conversion I -7,587,828 0
2021-07-02 2021-07-02 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Series E-2 Preferred Stock C - Conversion I -6,451,188 0
2021-07-02 2021-07-02 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Series D-2 Preferred Stock C - Conversion I -4,032,259 0
2021-07-02 2021-07-02 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. CVRX Common Stock C - Conversion I 3,495,575 3,495,575
2021-07-01 2021-06-29 4 VERRASTRO PAUL CVRX Stock Option (right to buy) A - Award D 18.00 19,000 19,000
2021-07-01 2021-06-29 4 BRUHN-DING DEAN CVRX Stock Option (right to buy) A - Award D 18.00 19,000 19,000
2021-07-01 2021-06-29 4 Galle Liz CVRX Stock Option (right to buy) A - Award D 18.00 19,700 19,700
2021-07-01 2021-06-29 4 Pardo Geoffrey B CVRX Stock Option (right to buy) A - Award D 18.00 10,382 10,382
2021-07-01 2021-06-29 4 Jain Mudit K. CVRX Stock Option (right to buy) A - Award D 18.00 10,382 10,382
2021-07-01 2021-06-29 4 NEHRA JOHN M CVRX Stock Option (right to buy) A - Award D 18.00 9,100 9,100
2021-07-01 2021-06-29 4 NEHRA JOHN M CVRX Stock Option (right to buy) A - Award D 18.00 10,382 10,382
2021-07-01 2021-06-29 4 BRINTNALL JOHN CVRX Stock Option (right to buy) A - Award D 18.00 18,300 18,300
2021-07-01 2021-06-29 4 Behbahani Ali CVRX Stock Option (right to buy) A - Award D 18.00 10,382 10,382
2021-07-01 2021-06-29 4 OASHEIM JARED CVRX Stock Option (right to buy) A - Award D 18.00 36,700 36,700
2021-07-01 2021-06-29 4 Yared Nadim CVRX Stock Option (right to buy) A - Award D 18.00 97,800 97,800
2021-07-01 2021-06-29 4 Nielsen Kirk G. CVRX Stock Option (right to buy) A - Award D 18.00 10,382 10,382
2021-07-01 2021-06-29 4 SLATTERY JOSEPH P CVRX Stock Option (right to buy) A - Award D 18.00 9,100 9,100
2021-07-01 2021-06-29 4 SLATTERY JOSEPH P CVRX Stock Option (right to buy) A - Award D 18.00 10,382 10,382
2021-06-29 3 SANDELL SCOTT D See Note 1 CVRX Common Stock I 1,384
2021-06-29 3 NEHRA JOHN M By trust CVRX Common Stock I 489
2021-06-29 3 BRINTNALL JOHN By trust CVRX Common Stock I 4,945
2021-06-29 3 BRINTNALL JOHN By spouse's trust CVRX Common Stock I 4,681
2021-06-29 3 BRUHN-DING DEAN CVRX Common Stock D 5,648
2021-06-29 3 Yared Nadim By trust for children CVRX Common Stock I 7,585
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista